Arrowhead Research Corporation earnings per share and revenue
On Nov 25, 2025, ARWR reported earnings of -0.18 USD per share (EPS) for Q4 25, beating the estimate of -0.24 USD, resulting in a 26.71% surprise. Revenue reached 256.47 million, compared to an expected 179.38 million, with a 42.98% difference. The market reacted with a +23.34% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 13 analysts forecast an EPS of 0.26 USD, with revenue projected to reach 275.47 million USD, implying an decrease of -244.44% EPS, and increase of 7.41% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
Dec 22, 2025 For Q4 25
Estimate
-$0.57
Actual
-$0.73
Surprise
-25.95%
Citius Oncology, Inc. Common Stock
Report Date
Dec 23, 2025 For Q4 25
Estimate
-$0.12
Actual
-$0.06
Surprise
+50.98%
FAQ
What were Arrowhead Research Corporation's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Arrowhead Research Corporation reported EPS of -$0.18, beating estimates by 26.71%, and revenue of $256.47M, 42.98% above expectations.
How did the market react to Arrowhead Research Corporation's Q4 2025 earnings?
The stock price moved up 23.34%, changed from $46.79 before the earnings release to $57.71 the day after.
When is Arrowhead Research Corporation expected to report next?
The next earning report is scheduled for Feb 09, 2026.
What are the forecasts for Arrowhead Research Corporation's next earnings report?
Based on 13
analysts, Arrowhead Research Corporation is expected to report EPS of $0.26 and revenue of $275.47M for Q1 2026.